Cyclic hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor with antitumor activity

Cancer Research

Volumn 61, Issue 11, 2001, Pages 4459-4466

  Komatsu, Yasuhiko ^a,f   Tomizaki, Kin ya ^b   Tsukamoto, Makiko ^b   Kato, Tamaki ^b,f   Nishino, Norikazu ^b,f   Sato, Shigeo ^c   Yamori, Takao ^c   Tsuruo, Takashi ^d   Furumai, Ryohei ^e,f   Yoshida, Minoru ^e,f   Horinouchi, Sueharu ^e   Hayashi, Hideya ^a  

^a JAPAN ENERGY CORPORATION   (Japan)

^b KYUSHU INSTITUTE OF TECHNOLOGY   (Japan)

^c CANCER CHEMOTHERAPY CENTER   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; CYCLOPEPTIDE; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID DERIVATIVE; OCTAPEPTIDE; PIPECOLIC ACID; TETRAPEPTIDE; TRAPOXIN; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CHIRALITY; CONTROLLED STUDY; DRUG POTENCY; DRUG STABILITY; DRUG SYNTHESIS; FEMALE; HUMAN; HUMAN CELL; HYDROPHOBICITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME INHIBITORS; HISTONE DEACETYLASES; HUMANS; HYDROXAMIC ACIDS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, NUDE; PEPTIDES, CYCLIC; PROLINE; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0035361402     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Three proteins define a class of human histone deacetylases related to yeast Hda1p
2. Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor
3. Isolation of a novel histone deacetylase reveals that class I and class Il deacetylases promote SMRT-mediated repression
4. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p
5. Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3
6. Isolation and characterization of cDNAs corresponding to an additional member of the human histone deacetylase gene family
7. Expression of differentiation-related markers in teratocarcinoma cells via histone hyperacetylation by trichostatin A
8. Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase
9. Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines
10. Induction of γ-globin by histone deacetylase inhibitors
11. Histone deacetylase inhibitors up-regulate the expression of cell surface MHC class-1 molecules in B16/BL6 cells
12. Structural specificity for biological activity of trichostatin A, a specific inhibitor of mammalian cell cycle with potent differentiation-inducing activity in Friend leukemia cells
13. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A
14. Inhibition of histone deacetylases: A new strategy to target epigenetic modifications for anticancer treatment
15. Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells
16. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor
17. A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors
18. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo
19. Role of the histone deacetylase complex in acute promyelocytic leukaemia
20. Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia
21. Distinct interactions of PML-RARα and PLZF-RARα with co- repressors determine differential responses to RA in APL
22. Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase
23. Apicidin: A novel antiprotozoal agent that inhibits parasite histone deacetylase
24. Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase
25. Amplification of recombinant adenoviral transgene products occurs by inhibition of histone deacetylase
26. Inhibition of maize histone deacetylases by HC toxin, the host-selective toxin of Cochliobolus carbonum
27. Depudecin induces morphological reversion of transformed fibroblasts via the inhibition of histone deacetylase
28. Analogues of trichostatin A and trapoxin B as histone deacetylase inhibitors
29. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases
30. Oxamflatin is a novel antitumor compound that inhibits mammalian histone deacetylase
31. Novel potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin
32. Expression of carbohydrate-binding protein p33/41 in human tumor cell lines
33. Comparison of seven cell lines derived from human gastric carcinomas
34. Sequence dependence in solid-phase-synthesis-cyclization-cleavage for cyclo-arginyl-glycylaspartyl-phenylglycyl
35. Synthesis of a cyclic tetrapeptide related to trapoxin B
36. A myeloma hybrid producing antibody specific for an allotypic determinant on "IgD-like" molecules of the mouse
37. Monoclonal antibodies as probes for differentiation and tumor-associated antigens: A Forssman specificity on teratocarcinoma stem cells
38. Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel
39. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors